| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 32.17B | 29.52B | 32.14B | 33.94B | 32.17B | 30.17B |
| Gross Profit | 13.49B | 10.77B | 12.93B | 13.12B | 11.85B | 11.08B |
| EBITDA | 6.20B | 6.29B | 7.09B | 6.90B | 6.10B | 5.61B |
| Net Income | 4.67B | 4.47B | 4.34B | 4.27B | 3.71B | 3.16B |
Balance Sheet | ||||||
| Total Assets | 53.19B | 52.68B | 51.42B | 49.26B | 50.31B | 46.56B |
| Cash, Cash Equivalents and Short-Term Investments | 22.94B | 19.24B | 20.00B | 24.79B | 20.54B | 17.38B |
| Total Debt | 344.37M | 240.16M | 68.24M | 63.39M | 373.08M | 406.99M |
| Total Liabilities | 20.01B | 18.18B | 21.56B | 21.00B | 24.04B | 22.77B |
| Stockholders Equity | 32.33B | 30.66B | 29.06B | 27.45B | 25.49B | 23.00B |
Cash Flow | ||||||
| Free Cash Flow | 3.89B | 2.82B | 3.01B | 1.16B | 3.10B | 4.41B |
| Operating Cash Flow | 6.26B | 5.02B | 5.15B | 2.78B | 4.88B | 6.04B |
| Investing Cash Flow | -2.15B | -3.71B | -7.42B | -3.46B | -2.20B | -10.25B |
| Financing Cash Flow | -3.14B | -3.02B | -2.98B | -2.87B | -1.68B | -1.61B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | HK$448.28M | 6.04 | 10.82% | 4.07% | 3.68% | ― | |
71 Outperform | HK$85.91B | 8.15 | 15.04% | 4.69% | 1.61% | 6.76% | |
70 Outperform | HK$87.07B | 23.27 | 1.45% | 3.42% | -1.89% | -30.46% | |
63 Neutral | HK$101.12B | 26.31 | 8.50% | 5.59% | -7.82% | -32.91% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
54 Neutral | HK$304.22M | 26.24 | 4.24% | 1.30% | -37.35% | -59.07% | |
42 Neutral | HK$487.80M | -61.50 | -16.93% | ― | 0.90% | 94.78% |